These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28993096)

  • 1. Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.
    Leti F; Legendre C; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
    Transl Res; 2017 Dec; 190():25-39.e21. PubMed ID: 28993096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma japonicum infection-mediated downregulation of lncRNA Malat1 contributes to schistosomiasis hepatic fibrosis by the Malat1/miR-96/Smad7 pathway.
    Jiang P; Ye S; Fan X; Tian Y; Zhang D; Pan W
    Parasit Vectors; 2024 Oct; 17(1):413. PubMed ID: 39363237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis.
    Li XQ; Ren ZX; Li K; Huang JJ; Huang ZT; Zhou TR; Cao HY; Zhang FX; Tan B
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
    Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
    J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis.
    Gerhard GS; Davis B; Wu X; Hanson A; Wilhelmsen D; Piras IS; Still CD; Chu X; Petrick AT; DiStefano JK
    Biochem Biophys Rep; 2020 Jul; 22():100753. PubMed ID: 32258441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis.
    Karri K; Waxman DJ
    RNA; 2023 Jul; 29(7):977-1006. PubMed ID: 37015806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p.
    Gerhard GS; Hanson A; Wilhelmsen D; Piras IS; Still CD; Chu X; Petrick AT; DiStefano JK
    PLoS One; 2019; 14(7):e0219764. PubMed ID: 31299062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis.
    Atanasovska B; Rensen SS; Marsman G; Shiri-Sverdlov R; Withoff S; Kuipers F; Wijmenga C; van de Sluis B; Fu J
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALAT1 promotes liver fibrosis by sponging miR‑181a and activating TLR4‑NF‑κB signaling.
    Wang Y; Mou Q; Zhu Z; Zhao L; Zhu L
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34651657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD.
    Li JZ; Ye LH; Wang DH; Zhang HC; Li TY; Liu ZQ; Dai EH; Li MR
    Virus Res; 2021 Jun; 298():198405. PubMed ID: 33775752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p.
    Hanson A; Piras IS; Wilhelmsen D; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
    Cytokine; 2019 Nov; 123():154789. PubMed ID: 31352173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
    Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
    Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
    Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data.
    Ma TT; Huang C; Ni Y; Yang Y; Li J
    Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease.
    Wiering L; Subramanian P; Hammerich L
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1277-1292. PubMed ID: 36828280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
    Kimura T; Singh S; Tanaka N; Umemura T
    Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage.
    Sookoian S; Flichman D; Garaycoechea ME; San Martino J; Castaño GO; Pirola CJ
    Hepatol Commun; 2018 Jun; 2(6):654-665. PubMed ID: 29881817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.